In blood, the transcription factor C/EBPa is essential for myeloid differentiation and has been implicated in regulating self-renewal of fetal liver haematopoietic stem cells (HSCs). However, its function in adult HSCs has remained unknown. Here, using an inducible knockout model we found that C/EBPa-deficient adult HSCs underwent a pronounced increase in number with enhanced proliferation, characteristics resembling fetal liver HSCs. Consistently, transcription profiling of C/EBPa-deficient HSCs revealed a gene expression program similar to fetal liver HSCs. Moreover, we observed that age-specific Cebpa expression correlated with its inhibitory effect on the HSC cell cycle. Mechanistically we identified N-Myc as a downstream target of C/EBPa, and loss of C/EBPa resulted in de-repression of N-Myc. Our data establish C/EBPa as a central determinant in the switch from fetal to adult HSCs.
Haematopoiesis is maintained by a small group of multipotent HSCs, which can rapidly divide and have the ability to remain quiescent. This ensures appropriate numbers of HSCs to sustain a sufficient supply of mature blood cells throughout the lifetime. During early development, fetal HSCs undergo rapid self-renewal divisions, which lead to a massive increase in cell number in the HSC pool to meet the demands of adult haematopoiesis 1, 2 . In contrast, adult HSCs divide infrequently with most cells in a quiescent G0 phase, and are maintained at relatively constant cell numbers [3] [4] [5] [6] [7] . New evidence now shows that the proliferation of HSCs continues until three weeks post-birth; afterwards HSCs undergo an abrupt change in their cycling activity and become quiescent at the end of the fourth week 8 . This process is also accompanied by alternations in differentiated cell output and self-renewal capacity of HSCs (refs 1,9,10) . Interestingly, these pronounced and coordinated changes in biological properties correlate with changes in HSC gene expression 10, 11 . It is clear that fetal and adult HSCs are sustained by different transcriptional programs. For instance, the transcription factor Sox17 is required for the maintenance of fetal and neonatal, but not adult, HSCs (ref. 11) . In contrast, Bmi-1 (ref. 12) , Gfi-1 (ref. 13) and Etv6 (ref. 14) are needed for self-renewal of adult, but not fetal, HSCs. However, the precise molecular circuitry that determines the transition of HSC properties during development remains unknown.
C/EBPa is a member of the basic leucine zipper transcription factor family, which regulates cell-cycle exit and differentiation in various tissues [15] [16] [17] . In the haematopoietic system, previous studies have established a critical, non-redundant role for C/EBPa in granulopoiesis. Disruption of C/EBPa blocks the transition from the common myeloid progenitors to the granulocyte/monocyte progenitor, thereby leading to the loss of mature granulocytes 18, 19 . In addition, we have previously reported that C/EBPa negatively regulates self-renewal of fetal HSCs, as Cebpa-null fetal liver HSCs exhibit enhanced repopulation activity in competitive transplantation assays, whereas their total number and cell-cycle kinetics are not affected 19 . C/EBPa also seems to be crucial in leukaemogenesis, as CEBPA silencing or mutations leading to reduced activity are frequently found in human acute myeloid leukaemia patients 20, 21 . However, despite the significance of C/EBPa in fetal haematopoiesis and human leukaemia, the physiological role of C/EBPa in adult haematopoiesis, especially in adult HSC biology, has remained unclear.
Here, using a Cebpa conditional knockout mouse model that circumvents the perinatal mortality of the conventional knockout mice, we demonstrate that loss of C/EBPa in adult HSCs confers fetal HSC characteristics, including enhanced proliferation, an increased number of functional long-term HSCs (LT-HSCs), advanced repopulating ability and an altered transcriptional profile that resembles that of Representative FACS plots analysing bone marrow cells 5-7 days after the last pIpC injections are shown for control (Ctl, a) and KO (b) mice. Numbers in plots indicate average percentages of outlined populations (±s.d.) among total bone marrow cells or gated populations (P < 0.005, data pooled from four independent experiments to obtain n = 15 per genotype). (c-e) Total numbers of bone marrow cells (c), KSLs (d), SLAM + KSLs (e) in the bone marrow (2 femurs, tibias and humerus) of Ctl and KO mice; mean values (±s.d.) are shown ( * * P < 0.01 and * * * P < 0.005, data pooled from four independent experiments to obtain n = 15 per genotype).
(f,g) Loss of C/EBPa increases the number of functional HSCs in adult mice. Limiting-dilution competitive repopulation analyses using either two doses (6 and 12 cells) of sorted SLAM + KSLs (f) or three doses (5,000, 20,000 and 50,000 cells) of whole bone marrow cells (g). Non-responders are defined as recipients with less than 0.3% donor-derived myeloid and/or lymphoid cells in nucleated peripheral blood cells. The frequency of functional HSCs (competitive repopulation units, CRU) was calculated according to Poisson statistics using L-Calc software (P < 0.005). (f) Plotted is the percentage of non-responders 24 weeks after transplantation versus the number of initial SLAM + KSLs from two independent experiments. (g) The frequency and the total number of CRU in bone marrow per mouse were measured and calculated. See also Supplementary Fig. S1 and Table S6 for raw values for Supplementary Fig. S1 .
fetal HSCs. Furthermore, we identified N-Myc as a downstream target of C/EBPa and showed that transcriptional repression of N-Myc by C/EBPa is at least partially required for acquiring and maintaining adult quiescence of HSCs.
RESULTS

Phenotypic LT-HSCs increase in adult C/EBPa-deficient mice
To address whether C/EBPa is involved in adult HSC function, we bred Cebpa loxP/loxP mice with transgenic Mx1-Cre mice to allow IFN-inducible Cebpa excision in adult haematopoietic cells. Administration of three doses of poly(inosinic acid) ·poly(cytidylic acid) (pIpC) in Mx1-Cre + C/EBPa loxP/loxP mice induced the excision of Cebpa in almost all c-Kit + Sca-1 + Lineage − haematopoietic stem and multipotent progenitor cells (HSPCs, also termed as KSLs) four days after the last injection (hereafter referred to as KO cells, Supplementary Fig. S1a,b) .
Phenotypic examination of HSCs by flow cytometry showed a ∼70-fold increase in the frequency of KSLs in KO bone marrow 5-7 days after pIpC treatment (Fig. 1a,b) . Despite the significant reduction in bone marrow cellularity (Fig. 1c) , the total number of KSLs increased nearly 12-fold in the bone marrow of KO mice (Fig. 1d ). KSLs were further analysed using the combination of CD150 and CD48 (SLAM code) for HSC identification. CD150 + CD48 − KSLs (hereafter referred to as SLAM + ) are enriched for LT-HSCs, whereas CD48 + KSLs contain short-term repopulating HSCs (ST-HSCs) and multipotent progenitors 22, 23 . Cebpa excision resulted in a decreased percentage of SLAM + cells within the KSL compartment of KO mice (Fig. 1a,b) ; however, the total number of SLAM + KSLs was increased by ∼2-fold (Fig. 1e) . Taken together, loss of C/EBPa led to an increased number of phenotypic LT-HSCs, despite a disproportionate increase in the number of ST-HSC/multipotent progenitors ( Supplementary Fig. S1c ). The results shown are the relative expression levels and expressed as fold difference compared with the levels (set to 1) detected in control SLAM + KSLs. The data are the averages ±s.d. for n = 3 independently sorted SLAM + KSLs per group two weeks after pIpC injections. The average for each sample was calculated from duplicate measurements. ( * * * P < 0.005, Gapdh normalization). See also Supplementary Fig. S3 and Table S6 for the raw data for b,g, Supplementary Fig. S3b,d .
Functional LT-HSCs are increased in C/EBPa-deficient mice
We next investigated whether the increased number of phenotypic SLAM + LT-HSCs in KO mice correlated with an increase in functional LT-HSCs. Limiting-dilution transplantation assays were performed to measure the frequency of competitive repopulation units 24 (CRU), which is a reflection of the number of functional HSCs. Analysis of recipients that have received either control or KO SLAM + KSLs revealed a ∼2-fold increase in the frequency of multipotent repopulating cells in KO (Fig. 1f) and a 4-5-fold increase in the number of functional LT-HSCs per mouse, when normalized to the total number of SLAM + KLSs (Fig. 1e) . The increased frequency and total number of functional LT-HSCs in KO mice were further confirmed by transplantation of unsorted whole bone marrow cells. Analysis of recipient animals revealed a 14-fold increase in the frequency of multipotent repopulating cells in KO mice and consequently a ∼5-fold increase in the number of CRU per mouse (Fig. 1g) . The presence of B and T cells, but the lack of donor-derived myeloid cells in bone marrow and peripheral blood, confirmed the reconstitution by KO cells (data not shown). Collectively, these results suggest that loss of C/EBPa leads to a significant increase in the number of functional LT-HSCs, which are highly enriched in the SLAM + KSL compartment.
Increase in cell number in the HSPC pool is cell intrinsic
To examine whether the increase in the number of KO Supplementary Fig. S2a ). Therefore, the increase in the number of KSLs in KO mice is a haematopoietic cell intrinsic event.
We also observed that Cebpa excision led to severe bone marrow cytopenia due to a myeloid differentiation block 19 . This raises the possibility that the increase in the number of KO HSPCs is a consequence of either the significant loss of haematopoietic cells or the lack of a myeloid population, an important component of the haematopoietic environment. To examine this, lethally irradiated CD45.1 + congenic recipients were reconstituted with undeleted CD45.2 + Mx1-Cre + Cebpa loxP/loxP or Mx1-Cre − Cebpa loxP/loxP bone marrow cells mixed with CD45.1 + congenic bone marrow cells at a 1:4 ratio. Two months after transplantation, mice were treated with pIpC ( Fig. 2d) . Assessment of the bone marrow one week later revealed a less than 10% reduction of bone marrow cellularity and a ∼15% decrease in Mac1 + Gr1 + myeloid cells in the KO chimaera mice (data not shown). Despite these minor changes in cell number, we found that the frequency of donor-derived KSLs in the Lin − population consistently exhibited a more than fivefold increase in the KO chimaeras, compared with control chimaeras ( Fig. 2e and Supplementary Fig. S2b ). Moreover, CD45.1 + wild-type congenic competitors in KO chimaeras showed little difference in KSL frequency compared to congenic competitors in the control chimaeras ( Fig. 2e and Supplementary Fig. S2b ). These results demonstrate that the increase in the number of KSLs observed in KO mice is not the consequence of cell loss or the lack of mature myeloid cells. Collectively, the increase in the number of KSLs is an intrinsic and HSC-specific effect of Cebpa deletion.
Loss of quiescence of adult HSCs on Cebpa excision
C/EBPa has previously been reported as a cell-cycle inhibitor 15 ; we therefore examined whether loss of C/EBPa increased the number of SLAM + LT-HSCs by enhancing cell-cycle activity. SLAM + KSL cells were stained with a combination of the DNA and RNA dyes Hoechst 33342 and Pyronin Y to distinguish cells in the G0, G1 and S-G2/M cell-cycle phases. Interestingly, we observed a 2-3-fold increase in the number of cells in the G1 and S-G2/M phases 5 days after pIpC treatment (Fig. 3a,b) . The 5 day interval was chosen to avoid secondary effects of pIpC-induced INFa production on HSC proliferation, as the transient effect of INFa on HSC proliferation diminishes 4 days after injections 25 . C/EBPa KO mice started to die 10 days following pIpC treatment owing to sepsis as a result of granulocytopenia 19 . To determine the long-term impact of C/EBPa deficiency on HSC proliferation, we created bone marrow chimaeric mice as described in Fig. 2d . Cebpa deletion was induced in reconstituted mice 4 month post-transplant and bone marrow cells were analysed 4 months later. Assessment of cellular proliferation by BrdU incorporation assays in these chimaeras revealed persistently increased proliferation of HSCs in the absence of C/EBPa (Fig. 3c,d ). Of note, the contribution of Cebpa-null cells graft was significantly increased after pIpC injection, as ∼80% of Table S1 .
SLAM
+ KSLs were derived from KO in KO chimaeras, compared with ∼20% from control in control chimaeras ( Supplementary Fig. S3a,b) . We further examined the reconstitution ability of KO cells in serial transplantation. The primary transplants as described above were treated with pIpC and two weeks later 2 × 10 6 unfractionated whole bone marrow cells were isolated and transplanted into irradiated CD45.1 + recipient mice. Four months after transplantation, we observed a marked increase in the number of KSLs with ∼90% of them being KO in mice that received the KO chimaera bone marrow. In contrast, mice that received the control chimaera bone marrow retained stable chimaerism in the KSL compartment ( Supplementary Fig. S3c,d) . These results indicate an enhanced competitive repopulation activity of proliferating KO cells. are shown (n = 3 of independent fetal liver KSL samples for each group, data collected over two experiments: one sample coming from one experiment and two from the other experiment, * * * P < 0.005, * P < 0.05). See also Supplementary  Fig. S4 and Table S6 for the raw data for a,d.
To further uncover the molecular basis for enhanced HSC proliferation in C/EBPa-deficient mice, we performed Affymetrixbased global gene expression analysis on SLAM + KSLs sorted from KO and control mice 7 and 21 days (only 4 out of 13 KO mice survived on day 21) after pIpC injections. In line with the functional cell-cycle analysis, gene set enrichment analysis (GSEA) revealed that the expression of proliferation-associated genes was significantly enriched in KO SLAM + KSLs on both day 7 and day 21 ( Fig. 3e and Supplementary Table S1), whereas the expression of quiescence-associated genes was markedly depleted in KOs (Fig. 3f and Supplementary Table S2) 26 . Quantitative PCR (qPCR) analysis confirmed that C/EBPa KO SLAM + KSLs exhibited significantly increased expression levels of mitotic cyclin A2, cyclin B2 and cyclin dependent kinase 4 (Cdk4), and a decreased expression level of the cell-cycle inhibitor p21, as compared with controls (Fig. 3g) .
In contrast to the cell-cycle alterations, no obvious difference in apoptosis was detected between KO and wild-type cells ( Supplementary  Fig. S3e ), suggesting that C/EBPa has a role in maintaining adult quiescence, but not in survival of HSCs.
Loss of Cebpa leads to transcriptional alterations that resemble fetal liver HSCs
Although the observed enhanced proliferation, yet expanded HSC pool and advanced reconstitution ability of KO HSCs are unusual phenomena for adult HSCs, they are hallmarks of fetal liver HSCs. This raises the possibility that loss of C/EBPa might restore a fetal transcriptional program in adult HSCs. We then compared the transcriptomes of adult KO, control and embryonic day (E)15.5 fetal liver HSCs. Unsupervised clustering analysis of differentially expressed genes (DEG) between KO and control cells showed that KO adult SLAM + KSLs co-clustered with fetal liver HSCs, with a distinguishable distance to control adult HSCs (Fig. 4a) . Among 1,551 DEGs between KO and control cells, 1,001 genes overlapped with the 1,934 DEGs identified by fetal liver and adult control HSC comparison (1.5-fold-change-filtered, P < 0.05). Of note, most of these overlapping genes (950 out of 1,001) were overexpressed or repressed accordingly in fetal liver HSCs and KO HSCs, as compared with control HSCs (Fig. 4b and Supplementary Table S3 ). Moreover, GSEA revealed that the expression of fetal liver-HSC-associated genes 27 was significantly enriched in KO adult HSCs, compared with control adult HSCs (Fig. 4c and Supplementary Table S4) . Thus, Cebpa deletion in adult HSCs leads to the restoration of the gene expression signature of fetal liver HSCs.
Increased levels of Cebpa correlate with the acquisition of adult quiescence in HSCs
Transition from actively dividing fetal HSCs to quiescent adult HSCs occurs 3-4 weeks after birth 8 . As C/EBPa KO HSCs failed to maintain properties of adult HSCs and yet acquired various characteristics of fetal liver HSCs, we then investigated whether C/EBPa regulates the developmental transition of HSC proliferation properties. First, we examined Cebpa expression in HSCs using qPCR and observed that levels of Cebpa increased during development (Fig. 5a) . Therefore, C/EBPa expression is inversely correlated with HSC proliferation 8 . Moreover, there was a sharp twofold increase in Cebpa expression in HSCs from 4-week-old mice, compared with HSCs from 2-week-old mice. Notably, this is consistent with the time at which HSCs switch to the non-proliferative state 8 . Next, we investigated whether levels of C/EBPa in HSCs correlate with inhibition of HSC proliferation. We excised Cebpa in 1.5-week-old and 4.5-week-old C/EBPa conditional KO mice, respectively. Assessment of proliferation by BrdU revealed that whereas there was a nearly twofold increase in the percentage of BrdU + SLAM + KSLs in 4.5-week KO mice (Fig. 5c ), no significant increase was observed in 1.5-week-old mice (Fig. 5b) . qPCR analysis also confirmed efficient excision of Cebpa in these cells (data not shown). Last, we examined whether overexpression of C/EBPa in fetal HSCs is sufficient to induce the switch from the proliferative to the quiescent state. Mac1 low KSLs isolated from fetal livers were transduced with either MSCV-GFP-C/EBPa (MIG-C/EBPa) or MIG control virus. GFP + c-kit + cells were isolated 48 h later and subjected to cell-cycle analysis. Strikingly, fetal liver KSLs overexpressing C/EBPa demonstrated a more than sevenfold increase in the number of cells 1.62 ; n = 4 independent samples per group, data pooled over two experiments, * * * P < 0.005 and * P < 0.05). See also Supplementary Fig. S5 and Table  S6 for the raw data for b-e,g,h and Supplementary Fig. S5a .
in the quiescent G0 phase, compared with cells infected with control vector, indicating a significantly decreased proliferation ( Fig. 5d and Supplementary Fig. S4 ). Together, these data suggest that increased C/EBPa expression contributes to the acquisition of adult HSC quiescence during ontogeny.
N-Myc is a direct target of C/EBPa and mediates its function in the fetal-to-adult switch of HSC proliferative properties
To identify potential C/EBPa downstream pathways involved, enriched pathway analysis using Ingenuity Systems Pathway Analysis (IPA) was performed on genes that were differentially expressed on excision of Cebpa in HSCs. In line with the increased level of proliferation observed, gene sets and pathways that associate with the cell cycle, cytoskeleton organization and HSC self-renewal (such as TGF-β and canonical Wnt signalling) were significantly over-represented in KO HSCs (Fig. 6a and Supplementary Table S5 ). The N-Myc target gene set was among the pathways and gene sets that were most significantly altered. N-Myc is a member of the MYC transcription factor family. Although elimination of either N-Myc or c-Myc in adult mice showed no effect on HSC proliferation, loss of both genes resulted in significantly decreased proliferation, suggesting either redundancy and/or a dosage effect of the Myc proteins on HSC proliferation 28 . To investigate whether N-Myc mediates the enhanced proliferation of KO HSCs, we first confirmed the increase of N-Myc messenger RNA in KO SLAM + KSLs by qPCR analysis (Fig. 6b) . To determine whether upregulation of N-Myc in HSCs is specifically caused by the loss of C/EBPa, we examined N-Myc expression in KO KSLs on the restoration of Cebpa expression and observed more than 90% downregulation of N-Myc expression (Fig. 6c) . Sequence analysis of the N-Myc promoter revealed three putative C/EBPa-binding sites within ∼1 kilobase of the proximal promoter region (Fig. 6e) . Combined with the rapid downregulation of N-Myc, this raised the possibility that C/EBPa modulates N-Myc expression through direct transcriptional repression. Chromatin immunoprecipitation (ChIP) in Lin − c-kit + bone marrow cells clearly showed binding of C/EBPa to the endogenous N-Myc promoter (Fig. 6d) . To further investigate how C/EBPa suppresses N-Myc transcription, we performed luciferase reporter assays with either the wild-type N-Myc promoter or its truncated mutants (Fig. 6e) . The luciferase activity of the construct containing all three binding sites was repressed by C/EBPa expression. Deletion of the two distal binding sites abolished the repression, suggesting that integrity of these consensus sites in the N-Myc promoter is required for C/EBPa-mediated suppression (Fig. 6e) . From these results, we concluded that C/EBPa directly represses N-Myc transcription by binding to the proximal region of the N-Myc promoter.
To determine whether increased expression of N-Myc is responsible for the enhanced proliferation of adult KO HSCs, we knocked down its expression in KO KSLs using lentivirally expressed short hairpin RNAs (shRNAs). Among the three shRNAs tested, N-Myc shRNA 42523 and 42524 showed a marked knockdown and were used in subsequent studies (Supplementary Fig. S5a ). Knocking down N-Myc by shRNA in KO KSLs led to a fourfold increase in the frequency of cells in the quiescent G0 phase, compared with cells infected with lentivirus carrying control luciferase shRNAs ( Fig. 6f and Supplementary Fig. S5b ). In contrast, knocking-down N-Myc in control adult KSLs showed no such effect on their cell cycle, indicating a specific contribution of N-Myc in C/EBPa-regulated HSC proliferation ( Supplementary Fig. S5c ).
To determine whether the quiescence imposed by increased Cebpa expression during the transition from fetal to adult haematopoiesis is also modulated through the inhibition of N-Myc expression, we first measured the mRNA levels of N-Myc in sorted SLAM + KSLs from fetal liver and from bone marrow of either newborn or adult mice. Of note, N-Myc showed an inverse expression pattern as compared with Cebpa (Fig. 6g) . To examine whether the relatively high levels of N-Myc in fetal liver HSCs mediate their active proliferation, we knocked down N-Myc expression in fetal liver KSLs using shRNA. Reduced levels of N-Myc in fetal liver KSLs resulted in a significant increase in the number of cells in the G0 phase (Fig. 6h) . Together, these data strongly support that the C/EBPa-regulated fetal-to-adult switch of HSCs is at least partially mediated by direct transcriptional repression of N-Myc by C/EBPa.
DISCUSSION
In this study, we demonstrate that deletion of C/EBPa leads to increased proliferation with an increase in cell number in the HSC pool.
Moreover, the transcriptome of adult C/EBPa KO HSCs resembled that of fetal HSCs. We identified N-Myc as a direct target of C/EBPa and a key mediator of the C/EBPa-induced transition from fetal to adult HSCs. Our data establish that a finely orchestrated balance of N-Myc and C/EBPa controls the developmental change of HSC proliferative properties (Fig. 7) .
One striking feature of HSCs is that actively dividing HSCs become quiescent around 3-4 weeks after birth 8 . However, the molecular mechanisms underlying this phenomenon are still under investigation 11, 27, 29 . Our data indicate that the fetal-to-adult switch of HSC is controlled by C/EBPa, probably in a dosage-sensitive manner. It is possible that different levels of C/EBPa control different downstream targets in HSCs through either direct transcriptional regulation or indirect mechanisms. For instance, low levels of C/EBPa may modulate genes essential for selfrenewal 19, 30 , whereas increased levels of C/EBPa in adult HSCs may regulate other sets of factors associated with the cell cycle. It is possible that a developmental stage-dependent bone marrow microenvironment triggers the activation of unique genetic programs in HSCs. However, the fact that the pace of HSC temporal alternation does not seem to be affected by the microenvironment following transplantation 10 rather suggests an intrinsically timed developmental event 31, 32 . The transcription factor Sox17 has been linked to the transition of fetal to adult HSCs. Sox17 is required for the maintenance of fetal and neonatal, but not adult, haematopoiesis 11, 27 . Moreover, ectopic expression of Sox17 confers fetal HSC characteristics to adult haematopoietic progenitors 27 . In C/EBPa KO SLAM + HSCs, we did not detect a change in Sox17 expression by microarray and qPCR (data not shown), suggesting that C/EBPa might function downstream of Sox17. This hypothesis is supported by the observation that Cebpa is significantly downregulated, whereas its downstream target N-Myc is upregulated, following the ectopic expression of Sox17 in adult haematopoietic progenitors 27 . Intriguingly, although C/EBPa adult KO HSCs exhibit an enhanced repopulation ability when compared with the wild-type control as well as enriched expression of fetal HSC-expressing genes, they are still unable to fully regain the reconstitution capacity of fetal HSCs, as evidenced by the lower frequency of reconstituted mice and the lower degree of chimaerism ( Supplementary Fig. S6a,b) . These data suggested that C/EBPa is a key factor, yet not the only one, that is crucial to fetal liver HSC identity and function. Other factors involved in HSC homing, engraftment and reconstitution might also be required.
Myc genes are associated with a variety of aspects of cellular physiology including proliferation, apoptosis, differentiation, cellular metabolism, and DNA synthesis 33 . Counteraction between C/EBPa and c-Myc has been reported in adipogenesis and myelopoiesis 34, 35 . However, loss of C/EBPa in HSCs did not significantly change the levels of c-Myc expression, nor did reduced levels of c-Myc by shRNA have an impact on the proliferation of KO HSPCs (data not shown). Therefore, it is less likely that elevated protein or enhanced activity levels of c-Myc contribute significantly to the proliferation of KO HSCs. Indeed, in this study we show that the enhanced proliferation exhibited in KO HSCs is at least partially mediated by N-Myc. We find that both C/EBPa KO HSCs with characteristics that resemble fetal HSCs and fetal liver HSCs themselves express high levels of N-Myc, and downregulating N-Myc in either of them diminishes HSC proliferation (Fig. 6) , indicating its crucial role in maintaining the active state of HSCs. It is likely that N-Myc activates yet to be identified genes modulating cell-cycle machinery. As loss of the mouse N-Myc gene results in embryonic lethality between E10.5 and E12.5 probably from neuroectodermal and heart defects 36, 37 , future investigations on HSC behaviour and its molecular profiling in mice in which the N-Myc gene is specifically disrupted in fetal haematopoiesis would be required to define pathways essential for HSC proliferation. It would also be interesting to know whether N-Myc-mediated proliferation also accounts for the increase in the number of functional LT-HSCs, which is seen both in C/EBPadeficient mice and wild-type fetal liver during early development.
We provide functional and genome-wide evidence that C/EBPa acts as a molecular switch for the acquisition and maintenance of adult HSC properties and demonstrate a remarkable capacity of a single transcription factor in the determination of HSC identity.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper
METHODS
Animals. All mice used in this study were housed in a sterile barrier facility approved by the IUCAC at the Beth Israel Deaconess Medical Center. C/EBPa conditional knockout (Cebpa loxP/loxP ) and Mx1-Cre mice have been described previously 19 . Cre-mediated site-specific recombination of the loxP cassettes was induced by intraperitoneal pIpC (Sigma) injection. Doses up to 30 µg g −1 mouse weight were given every other day for a total of three doses. Cebpa loxP/loxP mice lacking the Cre gene were treated in the same way and used as controls. The excision of the C/EBPa loxP allele was analysed by PCR using genomic DNA isolated from single-cell suspensions of bone marrow, spleen, thymus or sorted haematopoietic stem or progenitor cells. PCR was performed with the following primers: 5 -GCC TGG TAA GCC TAG CAA TCC T-3 (sense primer) and 5 -TGG AAA CTT GGG TTG GGT GT-3 (antisense primer), which gave rise to a 400-base-pair band for the excised allele. The annealing temperature was 60 • C.
Flow cytometry. Single-cell suspensions from various organs were analysed by flow cytometry using the following monoclonal antibodies conjugated with phycoerythrin (PE), PE-CY7, fluorescein isothiocyanate, allophycocyanin (APC), APC-Cy7 or eFluor 450 obtained from BD Pharmingen (BD), BioLegend or eBioscience: Mac-1/CD11b (M1/70), Gr-1 (8C5), CD3 (KT31.1), CD4 (GK1.5), CD8 (53-6.7), B220 (RA3-6B2), CD19 (1D3), TER119 (TER-119), Sca1 (E13-161-7), c-Kit (2B8), CD16/32 (2.4G3), Thy-1.2 ( 53-2.1), CD135 (AF2 10.1), CD48 (HM48-1), CD45.1 (A20), CD45.2 (104) and CD150 (TC15-12F12.2). Stained cells were analysed with an LSRII flow cytometer (BD Biosciences) or a FACSAria (BD Biosciences) and sorted using a FACSAria. Viable cells were identified by propidium iodide exclusion. The same numbers of total bone marrow cells are taken from C/EBPa KO and control bone marrow for HSC analysis. Diva software (BD) and FlowJo (Tree Star) were used for data acquisition and analysis, respectively.
qPCR. RNA was extracted by Trizol and the RNeasy kit (Qiagen), reverse transcribed using the Superscript First-Strand Synthesis System and quantitatively assessed using a Rotor-Gene 6000 real-time PCR machine (Corbett) with primers described elsewhere 6, 28, 38 . The specificity of the qPCR reactions was confirmed by examining the melting curves of the products and the presence of a single band of the expected size on 2% agarose gels. For each sample, transcript levels of tested genes were normalized to glyceraldehyde 3-phosphate dehydrogenase (Gapdh).
For the experiment shown in Fig. 6c , C/EBPa KO KSLs were sorted and transduced with either MIG or MIG-C/EBPa. The mRNA levels of C/EBPa and N-Myc in the sorted GFP + population were measured 48 h after infection.
Cell-cycle analysis. Mice were given a single intraperitoneal injection of 5-bromodeoxyuridine (BrdU; 100 µg BrdU g −1 mouse weight) and then maintained on 0.8 mg ml −1 BrdU in the drinking water for 14 or 20 h before being euthanized. SLAM + KSLs were double FACS-sorted from mouse bone marrow. BrdU incorporation was measured by flow cytometry using a APC BrdU Flow Kit (BD Pharmingen) according to the manufacturer's instructions. For Hoechst/Pyronin Y staining, purified haematopoietic stem and progenitor cells were suspended in phosphate-citrate buffer solution with 0.02% saponin for permeabilization, and then incubated with Hoechst 33342 (Invitrogen) and Pyronin Y (Sigma-Aldrich) as previously described 39 . For the experiment shown in Fig. 6f ,h, KSLs from C/EBPa-deficient mouse bone marrow 2 weeks following pIpC injections or Mac1 low KSLs from fetal liver were transduced by pLKO.1-neo lentiviruses containing control luciferase shRNA (gift from G. Gilliland, Children's Hospital Boston, USA) and N-Myc shRNAs (Sigma, MISSION shRNA TRCN000004254 and TRCN000004253) immediately. Sixteen hours post-transduction, transduced cells were selected by puromycin (2 µg ml −1 ) for 36 h. Cells then were collected and subjected to Hoechst 33342/Pyronin Y staining for cell-cycle analysis. Recombinant murine cytokines (PeproTech) were present in the following concentrations: SCF 100 ng ml −1 , TPO 100 ng ml −1 and IL-3 10 ng ml −1 .
Limiting-dilution long-term competitive reconstitution assay. SLAM + KSLs or total bone marrow cells were collected from CD45.2 + Mx1-Cre − Cebpa loxP/loxP or Mx1-Cre + Cebpa loxP/loxP mice 1 week following pIpC injections; then the number of cells to be injected per mouse (6 and 12 SLAM + KSLs or 5,000, 20,000 and 50,000 bone marrow cells) was sorted into individual wells of a 96-well plate containing 2 × 10 5 CD45.1 + or CD45.1 + CD45.2 + whole bone marrow cells in PBS. The contents of individual wells were injected into the retro-orbital venous sinus of lethally irradiated CD45.1 + recipients (600 rads twice with a 3 h interval). Microarray analysis. SLAM + KSL cells were sorted from E15.5 fetal liver and from adult C/EBPa KO and control mouse bone marrow 7 days or 21 days after pIpC treatment. Total RNA was isolated using an RNeasy microkit (QIAGEN) and treated with RNase-free DNase (QIAGEN). A total of 5 ng of purified total RNA was amplified using the Ovation Pico WTA System V2 (Nugen), and biotinylated with fetal liver-Ovation Biotin Module Version 2 (Nugen), according to the supplied protocol. Complementary DNA was then hybridized to Affymetrix mouse expression array 430A2.0 chips by the NUS-Duke genomic facility. Expression values for all genes were calculated using the robust multi-array average method 40 . Gene expression was normalized between chips on the basis of the cross-correlation method 41 . For the identification of genes with differential expression between groups, fold-change cutoff (≥1.5) and P-value cutoff (≤0.05) were used for differential expression. Gene sets were tested for enrichment for C/EBPa knockout versus control using GSEA (ref. 42) . HSC proliferation and quiescence gene sets were curated from ref. 26 , and the fetal liver-HSC-specific gene set was from ref. 27 . Enriched pathway analysis using IPA was performed for the differentially expressed genes on the loss of C/EBPa. In addition to the collections of pathways and gene sets in the IPA database, we also included a few putative target gene sets in the enriched pathway analysis. Student t -statistics were used for identification of differential expression, and P values for the enriched pathway analysis were calculated on the basis of the Fisher exact test and further corrected using the Benjamini and Hochberg method. Results for gene set analysis were filtered for statistical significance using a nominal P-value threshold of 0.05.
Luciferase assay. The full-length ∼1.1 kilobase murine N-Myc promoter, extending from base pair −986 to +105 relative to the major N-Myc transcription start site, and two deletion mutants were amplified by PCR of BL6 mouse genomic DNA and cloned into the pXP2 luciferase reporter vector. HEK293 cells were co-transfected with luciferase reporter constructs, a C/EBPa expression construct and a Renilla luciferase construct for standardization. Luciferase assays were performed using the Dual Luciferase Reporter Assay System (Promega) and normalized to Renilla activity according to the manufacturer's instructions.
ChIP assay. Lin − c-kit + bone marrow cells (10 6 for each antibody) were used to crosslink chromatin using the protocol from Millipore, with minor modifications. Briefly, cells were incubated in 1% formaldehyde for 10 min at room temperature. Glycine (0.125 M) was added to stop crosslinking. Crosslinked chromatin was sonicated for 150 s at 30% amplitude (Branson Digital Sonifer). Polyclonal antibodies raised against C/EBPa (Santa Cruz) and the IgG control (Millipore) were used in the assay. DNA was purified by phenol-chloroform extraction, and specific regions were amplified by qPCR. Primers used were the following: forward, 5 -CACAAAGAGGCCAAATTAATGATGG-3 ; reverse, 5 -TCGCGGAGA CCAAGCAGAA-3 .
Statistical analysis. CRU frequencies were calculated from the proportions of negative recipients in a limiting-dilution setting with L-calc software (StemCell),
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which uses Poisson statistics and the method of maximum likelihood. The statistical differences in frequencies between paired sets of limiting-dilution analyses were assessed on the basis of the asymptotic normality of the maximum likelihood estimates and calculated using the chi-squared test. Otherwise, the statistical significances were assessed by Student's unpaired t -test; * P < 0.05; * * P < 0.01; * * * P < 0.005.
The GEO accession number for the microarray data is GSE42234.
Figure S1 Primary recipients was generated and subjected to pIpC treatment as described above. Two weeks after last pIpC injection, 2x10 6 unfractionated whole bone marrow cells from chimeras were used for secondary transplantation. Bone marrow cells from the secondary recipients were analyzed four months after transplantation. Table S4 : Genes listed in fetal liver HSC signature and their differential expression in C/EBPa KO and control HSCs Table S5 . Gene set/Pathways signifcantly affected by C/EBPa excision in HSCs Table S6 shows a collection of raw data for results with the number of independent experiments below 5.
